Skip to Main Content

Even as hopes soar that soon-to-be-distributed Covid-19 vaccines will help quench the global coronavirus pandemic, there are still concerns about the rapid speed with which these vaccines were developed. And with some estimates suggesting that the global Covid-19 vaccine market could surpass $40 billion in 2021 alone, this scrutiny is likely to continue.

It is a tension replicated across a range of other activities in the sector. As Liz Szabo wrote last year in Scientific American, “Many doctors and consumer advocates fear that the tech industry, which lives by the mantra ‘fail fast and fix it later,’ is putting patients at risk — and that regulators aren’t doing enough to keep consumers safe.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!